Brokerages Set Oscar Health, Inc. (NYSE:OSCR) Price Target at $21.56

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $21.56.

OSCR has been the subject of several recent analyst reports. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Piper Sandler reissued an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Finally, Jefferies Financial Group initiated coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock.

Insider Transactions at Oscar Health

In related news, Vice Chairman Joshua Kushner acquired 276,040 shares of the stock in a transaction dated Monday, November 11th. The shares were purchased at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the transaction, the insider now directly owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This represents a 5.80 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Mario Schlosser sold 6,516 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the transaction, the insider now owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. This trade represents a 7.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have acquired 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

Several institutional investors and hedge funds have recently modified their holdings of the company. Westfield Capital Management Co. LP purchased a new stake in Oscar Health in the 3rd quarter worth $27,452,000. Renaissance Technologies LLC boosted its stake in shares of Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after acquiring an additional 934,600 shares during the period. Point72 Asset Management L.P. purchased a new stake in shares of Oscar Health during the second quarter worth about $14,716,000. Bank of New York Mellon Corp raised its stake in Oscar Health by 161.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after purchasing an additional 860,226 shares during the period. Finally, Soros Fund Management LLC purchased a new position in Oscar Health in the 3rd quarter worth approximately $12,726,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Stock Performance

Shares of OSCR stock opened at $13.40 on Wednesday. The company has a market capitalization of $3.31 billion, a price-to-earnings ratio of -223.30 and a beta of 1.63. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health has a one year low of $8.44 and a one year high of $23.79. The company’s 50-day moving average is $15.81 and its 200 day moving average is $17.35.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.33 billion. During the same quarter in the previous year, the company earned ($0.29) EPS. The company’s quarterly revenue was up 68.3% compared to the same quarter last year. Sell-side analysts expect that Oscar Health will post -0.01 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.